The progress of the soluble suppression of tumorigenicity 2 (sST2) in atrial fibrillation

被引：5
|
作者：
Liu, Jia-Hui [1 ]
Han, Qian-Feng [1 ]
Mo, De-Gang [1 ]
机构：
[1] Shandong First Med Univ, Liaocheng Peoples Hosp, Dept Cardiol, Liaocheng 252000, Shandong, Peoples R China
来源：
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY | 2022年 / 65卷 / 03期
关键词：
D O I：
10.1007/s10840-022-01346-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：591 / 592
页数：2
相关论文
共 50 条
  • [41] Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1
    Sun, Wei-Ping
    Du, Xiao
    Chen, Jun-Jun
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022
  • [42] Myocardial-alternation index (MMI) is correlated with soluble suppression of tumorigenecity-2 (sST2) in patients with ischemic cardiomyopathy
    Andra Naufal Pramanda
    Fatih Farabi
    Hawani Sasmaya Prameswari
    Chaerul Achmad
    Badai Bhatara Tiksnadi
    The Egyptian Heart Journal, 77 (1)
  • [43] sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells
    Delesque, N
    Buscail, L
    Esteve, JP
    SaintLaurent, N
    Muller, C
    Weckbecker, G
    Bruns, C
    Vaysse, N
    Susini, C
    CANCER RESEARCH, 1997, 57 (05) : 956 - 962
  • [44] Cellular Noise Suppression by the Regulator of G Protein Signaling Sst2
    Dixit, Gauri
    Kelley, Joshua B.
    Houser, John R.
    Elston, Timothy C.
    Dohlman, Henrik G.
    MOLECULAR CELL, 2014, 55 (01) : 85 - 96
  • [45] Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
    Stojkovic, Stefan
    Demyanets, Svitlana
    Kopp, Christoph W.
    Hengstenberg, Christian
    Wojta, Johann
    Eichelberger, Beate
    Panzer, Simon
    Gremmel, Thomas
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [46] Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease
    Nortamo, Santeri
    Ukkola, Olavi
    Lepojarvi, Samuli
    Kentta, Tuomas
    Kiviniemi, Antti
    Junttila, Juhani
    Huikuri, Heikki
    Perkiomaki, Juha
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 : 173 - 178
  • [47] Elevated Plasma Concentrations Of Soluble Suppressor Of Tumorigenicity-2 (sst2) Accurately Discriminates Acute Respiratory Distress Syndrome From Acute Heart Failure
    Levy, S. D.
    Thompson, B. T.
    Matthay, M. A.
    Januzzi, J. L.
    Christiani, D. C.
    Bajwa, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [48] Soluble ST2 (sST2) as potential marker for hepatic cystic echinococcosis activity
    An, Mengting
    Zhu, Yuejie
    Xu, Cheng
    Li, Yujiao
    Pang, Nannan
    Zhao, Xiao
    Li, Zhiwei
    Wang, Hongying
    Zhang, Fengbo
    Ding, Jianbing
    JOURNAL OF INFECTION, 2020, 80 (04) : 462 - 468
  • [49] Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus
    Man Li
    Lei Duan
    Yulun Cai
    Benchuan Hao
    Jianqiao Chen
    Huiying Li
    Hongbin Liu
    Cardiovascular Diabetology, 20
  • [50] Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus
    Li, Man
    Duan, Lei
    Cai, Yulun
    Hao, Benchuan
    Chen, Jianqiao
    Li, Huiying
    Liu, Hongbin
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
12345